APA

Weinstein G. D., Koo J. Y. M., Krueger G. G., Lebwohl M. G., Lowe N. J., Menter M. A., Lew-Kaya D. A., Sefton J., Gibson J. R. & Walker P. S. (20030609). Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. : Journal of the American Academy of Dermatology.

Chicago

Weinstein Gerald D, Koo John Y M, Krueger Gerald G, Lebwohl Mark G, Lowe Nicholas J, Menter M Alan, Lew-Kaya Deborah A, Sefton John, Gibson John R and Walker Patricia S. 20030609. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. : Journal of the American Academy of Dermatology.

Harvard

Weinstein G. D., Koo J. Y. M., Krueger G. G., Lebwohl M. G., Lowe N. J., Menter M. A., Lew-Kaya D. A., Sefton J., Gibson J. R. and Walker P. S. (20030609). Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. : Journal of the American Academy of Dermatology.

MLA

Weinstein Gerald D, Koo John Y M, Krueger Gerald G, Lebwohl Mark G, Lowe Nicholas J, Menter M Alan, Lew-Kaya Deborah A, Sefton John, Gibson John R and Walker Patricia S. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. : Journal of the American Academy of Dermatology. 20030609.